董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Marc Mazur | 男 | Director | 62 | 未披露 | 未持股 | 2022-12-07 |
| Hillel Weinberger | 男 | Director | 69 | 未披露 | 未持股 | 2022-12-07 |
| Jay R. Bloom | 男 | Co-Chairman and Chief Executive Officer | 67 | 未披露 | 未持股 | 2022-12-07 |
| Dean C. Kehler | 男 | Co-Chairman and Chief Executive Officer | 65 | 未披露 | 未持股 | 2022-12-07 |
| Hillel Weinberger | 男 | Director | 69 | 未披露 | 未持股 | 2022-12-07 |
| Marc Mazur | 男 | Director | 63 | 未披露 | 未持股 | 2022-12-07 |
| James W. Harpel | 男 | Director | 85 | 未披露 | 未持股 | 2022-12-07 |
| Dean C. Kehler | 男 | Co-Chairman and Chief Executive Officer | 65 | 未披露 | 未持股 | 2022-12-07 |
| Jay R. Bloom | 男 | Co-Chairman and Chief Executive Officer | 67 | 未披露 | 未持股 | 2022-12-07 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Andrea J. Kellett | 女 | Chief Financial Officer | 66 | 未披露 | 未持股 | 2022-12-07 |
| Jay R. Bloom | 男 | Co-Chairman and Chief Executive Officer | 67 | 未披露 | 未持股 | 2022-12-07 |
| Dean C. Kehler | 男 | Co-Chairman and Chief Executive Officer | 65 | 未披露 | 未持股 | 2022-12-07 |
| Michael G. Maselli | 男 | President | 62 | 未披露 | 未持股 | 2022-12-07 |
| Andrea J. Kellett | 女 | Chief Financial Officer | 66 | 未披露 | 未持股 | 2022-12-07 |
| Arthur D. Baer | 男 | Vice President | 44 | 未披露 | 未持股 | 2022-12-07 |
| Jordan S. Bloom | 男 | Vice President | 33 | 未披露 | 未持股 | 2022-12-07 |
| Dean C. Kehler | 男 | Co-Chairman and Chief Executive Officer | 65 | 未披露 | 未持股 | 2022-12-07 |
| Jay R. Bloom | 男 | Co-Chairman and Chief Executive Officer | 67 | 未披露 | 未持股 | 2022-12-07 |
| Michael G. Maselli | 男 | President | 62 | 未披露 | 未持股 | 2022-12-07 |
董事简历
中英对照 | 中文 | 英文- Marc Mazur
-
Marc Mazur，自2019年5月以来，我们的董事之一自2014年以来一直担任私人债务基金Brightwood Capital Advisors，LLC的行业顾问。从2006年到2008年，Mazur先生担任Brevan Howard U.S.Asset Management的首席执行官，这是一家总部位于伦敦的全球宏观对冲基金，并担任该公司的高级顾问直到2010年。从2010年到2019年12月，Mazur先生担任FibrocellScience，Inc.董事会成员纳斯达克股票代码:FCSC，一家自体细胞和基因治疗公司。Mazur先生还曾担任Sutter Rock Capital（纳斯达克股票代码:SSSS）（原GSV Capital Corp（纳斯达克股票代码:GSVC））的审计委员会主席和估值委员会成员，该公司是一家业务开发公司，自2017年起投资于后期风险投资支持的私人公司。他从2001年到2005年担任Tsinghua Venture Capital高级顾问。Mazur先生从1984年到1987年担任所罗门兄弟公司（Salomon Brothers，Inc）的Vice President，从1987年到1996年担任高盛集团固定收益部的Vice President，从1997年到1999年担任高盛的顾问。从2010年到2014年，他曾担任Staywell Health公司的董事，以及Devilbiss Health公司（健康和医疗设备领域的私人公司）的董事。Mazur先生在哥伦比亚大学（Columbia University）获得政治学学士学位，在维拉诺瓦大学法学院（Villanova University School of Law）获得法学博士学位。
Marc Mazur serves as a member of Board of Directors. Since 2014, Mr. Mazur has served as an Indtry Advisor to Brightwood Capital Advisors, LLC, a private debt fund. Further, since Augt 2024, Mr. Mazur has served as a member of the Board of Directors of American Addiction Centers. Prior to joining the American Addiction Center Board of Directors, Mr. Mazur served as a member of the Board of Directors for Celularity Inc. from July 2021 to July 2024, Fibrocell Science, Inc. (NASDAQ: FCSC), an autologo cell and gene therapy company, from April 2010 to December 2019, GX Acquisition Corp., a SPAC which was the predecessor to Celularity Inc. upon its biness combination, from May 2019 to July 2021, and GX Acquisition Corp. II, a SPAC, from February 2021 to March 2023 upon the completion of its biness combination. Additionally, Mr. Mazur previoly served as the Chief Executive Officer of Brevan Howard U.S. Asset Management, a London based global macro hedge fund, and as a senior advisor of such company until 2010. He also previoly served as a senior advisor to Tsinghua Venture Capital Company. Mr. Mazur served in management roles at Salomon Brothers, Inc., The Goldman Sachs Group, Inc. from 1987 until 1996, and served as a consultant for Goldman from 1997 to 1999. Prior to his time at Goldman Sachs, Mr. Mazur served as an executive with Careinsite and served as a director of Stayll Health, DeVilbiss Healthcare, ChanceLight Behavioral Health and other private companies in the llness, addiction treatment, homecare and medical device fields. Mr. Mazur received his B.A. in Political Science from Columbia University and a J.D. from Villanova University School of Law. - Marc Mazur，自2019年5月以来，我们的董事之一自2014年以来一直担任私人债务基金Brightwood Capital Advisors，LLC的行业顾问。从2006年到2008年，Mazur先生担任Brevan Howard U.S.Asset Management的首席执行官，这是一家总部位于伦敦的全球宏观对冲基金，并担任该公司的高级顾问直到2010年。从2010年到2019年12月，Mazur先生担任FibrocellScience，Inc.董事会成员纳斯达克股票代码:FCSC，一家自体细胞和基因治疗公司。Mazur先生还曾担任Sutter Rock Capital（纳斯达克股票代码:SSSS）（原GSV Capital Corp（纳斯达克股票代码:GSVC））的审计委员会主席和估值委员会成员，该公司是一家业务开发公司，自2017年起投资于后期风险投资支持的私人公司。他从2001年到2005年担任Tsinghua Venture Capital高级顾问。Mazur先生从1984年到1987年担任所罗门兄弟公司（Salomon Brothers，Inc）的Vice President，从1987年到1996年担任高盛集团固定收益部的Vice President，从1997年到1999年担任高盛的顾问。从2010年到2014年，他曾担任Staywell Health公司的董事，以及Devilbiss Health公司（健康和医疗设备领域的私人公司）的董事。Mazur先生在哥伦比亚大学（Columbia University）获得政治学学士学位，在维拉诺瓦大学法学院（Villanova University School of Law）获得法学博士学位。
- Marc Mazur serves as a member of Board of Directors. Since 2014, Mr. Mazur has served as an Indtry Advisor to Brightwood Capital Advisors, LLC, a private debt fund. Further, since Augt 2024, Mr. Mazur has served as a member of the Board of Directors of American Addiction Centers. Prior to joining the American Addiction Center Board of Directors, Mr. Mazur served as a member of the Board of Directors for Celularity Inc. from July 2021 to July 2024, Fibrocell Science, Inc. (NASDAQ: FCSC), an autologo cell and gene therapy company, from April 2010 to December 2019, GX Acquisition Corp., a SPAC which was the predecessor to Celularity Inc. upon its biness combination, from May 2019 to July 2021, and GX Acquisition Corp. II, a SPAC, from February 2021 to March 2023 upon the completion of its biness combination. Additionally, Mr. Mazur previoly served as the Chief Executive Officer of Brevan Howard U.S. Asset Management, a London based global macro hedge fund, and as a senior advisor of such company until 2010. He also previoly served as a senior advisor to Tsinghua Venture Capital Company. Mr. Mazur served in management roles at Salomon Brothers, Inc., The Goldman Sachs Group, Inc. from 1987 until 1996, and served as a consultant for Goldman from 1997 to 1999. Prior to his time at Goldman Sachs, Mr. Mazur served as an executive with Careinsite and served as a director of Stayll Health, DeVilbiss Healthcare, ChanceLight Behavioral Health and other private companies in the llness, addiction treatment, homecare and medical device fields. Mr. Mazur received his B.A. in Political Science from Columbia University and a J.D. from Villanova University School of Law.
- Hillel Weinberger
-
Hillel Weinberger，自2019年5月以来，我们的董事之一自2010年以来一直担任海澜之家（一家私人风险投资公司）的负责人。在此之前，从2007年到现在，Weinberger先生是Hillmark Capital Management，L.P.的联合创始人，在此之前，从1988年到2006年是财产和意外伤害保险公司Loews/CNA Holdings的高级副总裁。此前，他曾担任Presidential Life公司的高级副总裁（1982年至1988年）。他曾任职Global Crossing Ltd.Telecommunications（纽约证券交易所代码:GX）的董事会（从1997年到2000年），在那里他曾担任审计委员会主席，以及News Communications，Inc.（报纸和杂志出版）的董事会（从1990年到1993年）。Weinberger先生曾就读Temple University和Benjamin N.Cardozo School of Law。
Hillel Weinberger, one of our directors since May 2019 has since 2010 been a Principal of HLA, a privately-owned venture capital firm. Prior to this, from 2007 to the present, Mr. Weinberger has been co-founder of Hillmark Capital Management, L.P., and before this was a Senior Vice-President of Loews/CNA Holdings, a property and casualty insurance company, from 1988 to 2006. Prior thereto he was a Senior Vice-President of Presidential Life, from 1982 to 1988. He has served on the boards of Global Crossing Ltd. telecommunications; NYSE: GX from 1997 to 2000 where he chaired the Audit Committee, and News Communications, Inc. (newspaper and magazine publishing) from 1990 to 1993. Mr. Weinberger attended Temple University and the Benjamin N. Cardozo School of Law. - Hillel Weinberger，自2019年5月以来，我们的董事之一自2010年以来一直担任海澜之家（一家私人风险投资公司）的负责人。在此之前，从2007年到现在，Weinberger先生是Hillmark Capital Management，L.P.的联合创始人，在此之前，从1988年到2006年是财产和意外伤害保险公司Loews/CNA Holdings的高级副总裁。此前，他曾担任Presidential Life公司的高级副总裁（1982年至1988年）。他曾任职Global Crossing Ltd.Telecommunications（纽约证券交易所代码:GX）的董事会（从1997年到2000年），在那里他曾担任审计委员会主席，以及News Communications，Inc.（报纸和杂志出版）的董事会（从1990年到1993年）。Weinberger先生曾就读Temple University和Benjamin N.Cardozo School of Law。
- Hillel Weinberger, one of our directors since May 2019 has since 2010 been a Principal of HLA, a privately-owned venture capital firm. Prior to this, from 2007 to the present, Mr. Weinberger has been co-founder of Hillmark Capital Management, L.P., and before this was a Senior Vice-President of Loews/CNA Holdings, a property and casualty insurance company, from 1988 to 2006. Prior thereto he was a Senior Vice-President of Presidential Life, from 1982 to 1988. He has served on the boards of Global Crossing Ltd. telecommunications; NYSE: GX from 1997 to 2000 where he chaired the Audit Committee, and News Communications, Inc. (newspaper and magazine publishing) from 1990 to 1993. Mr. Weinberger attended Temple University and the Benjamin N. Cardozo School of Law.
- Jay R. Bloom
-
Jay R. Bloom自成立以来一直担任Gx Acquisition Corp. ii的联席主席兼首席执行官，是Trimaran Fund Management，L.L.C. d/b/a Trimaran Capital Partners（“Trimaran”）的管理合伙人，他于1998年与他人共同创立了Trimaran Capital Partners（“Trimaran”），并担任现有的私募股权基金Trimaran Fund II的经理。Trimaran及其附属实体管理着私人股本基金、抵押贷款债务和对冲基金（就对冲基金而言，作为次级顾问）。在加入Trimaran之前，Bloom先生是CIBC World Markets Corp.（“CIBC”）的董事总经理和副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，布卢姆还负责监管CIBC在美国和欧洲的杠杆融资业务，包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Bloom先生是The Argosy Group，LP（“Argosy”）的联合创始人，该公司是一家从事杠杆融资活动和本金投资的精品投资银行。Argosy于1995年被CIBC收购。在Argosy之前，布卢姆是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。布卢姆还在Paul Weiss Rifkind Wharton & Garrison从事法律工作。Bloom先生自2021年7月起担任Celularity（生物科技；纳斯达克股票代码：CELU）的董事会成员。布卢姆还曾在多个不同行业的私营和上市公司的董事会任职。他曾在哥伦比亚大学里奇曼商业、法律和公共政策中心顾问委员会任职，是康奈尔大学理事会和康奈尔大学本科生商业项目顾问委员会的成员，并且是康奈尔大学约翰逊管理研究生院顾问委员会的名誉成员。Bloom先生以优异成绩毕业于康奈尔大学，获得学士学位，毕业于约翰逊研究生院，获得工商管理硕士学位，毕业于哥伦比亚大学法学院，获得法学博士学位，并担任《哥伦比亚法律评论》编辑委员会成员。
Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review. - Jay R. Bloom自成立以来一直担任Gx Acquisition Corp. ii的联席主席兼首席执行官，是Trimaran Fund Management，L.L.C. d/b/a Trimaran Capital Partners（“Trimaran”）的管理合伙人，他于1998年与他人共同创立了Trimaran Capital Partners（“Trimaran”），并担任现有的私募股权基金Trimaran Fund II的经理。Trimaran及其附属实体管理着私人股本基金、抵押贷款债务和对冲基金（就对冲基金而言，作为次级顾问）。在加入Trimaran之前，Bloom先生是CIBC World Markets Corp.（“CIBC”）的董事总经理和副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，布卢姆还负责监管CIBC在美国和欧洲的杠杆融资业务，包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Bloom先生是The Argosy Group，LP（“Argosy”）的联合创始人，该公司是一家从事杠杆融资活动和本金投资的精品投资银行。Argosy于1995年被CIBC收购。在Argosy之前，布卢姆是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。布卢姆还在Paul Weiss Rifkind Wharton & Garrison从事法律工作。Bloom先生自2021年7月起担任Celularity（生物科技；纳斯达克股票代码：CELU）的董事会成员。布卢姆还曾在多个不同行业的私营和上市公司的董事会任职。他曾在哥伦比亚大学里奇曼商业、法律和公共政策中心顾问委员会任职，是康奈尔大学理事会和康奈尔大学本科生商业项目顾问委员会的成员，并且是康奈尔大学约翰逊管理研究生院顾问委员会的名誉成员。Bloom先生以优异成绩毕业于康奈尔大学，获得学士学位，毕业于约翰逊研究生院，获得工商管理硕士学位，毕业于哥伦比亚大学法学院，获得法学博士学位，并担任《哥伦比亚法律评论》编辑委员会成员。
- Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review.
- Dean C. Kehler
-
Dean C. Kehler，Gx Acquisition Corp. ii自成立以来担任联席主席兼首席执行官，是Trimaran的管理合伙人，他于1998年与他人共同创立了Trimaran基金II，并担任该基金的经理。2018年8月至2021年7月，他在GX Acquisition Corp.担任联席董事长兼首席执行官，GX Acquisition Corp.是一家与Celularity Inc.合并的特殊目的收购公司。在Trimaran之前，Kehler先生是CIBC的董事总经理兼副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆融资业务，这些业务包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生目前分别在Celularity（生物技术股票代码：CELU）董事会以及El Pollo Loco和KCAP董事会任职。凯勒先生还曾在许多跨越各个行业的私营和上市公司的董事会任职。Kehler先生曾担任世界上最大的私营人道主义组织之一的CARE USA的主任、财务主任和财务委员会主席；以及宾夕法尼亚大学护理学院监督委员会主席。Kehler先生毕业于宾夕法尼亚大学沃顿商学院。
Dean C. Kehler, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran, which he co-founded in 1998, and serves as a Manager of Trimaran Fund II. From August 2018 to July 2021, he served as Co-Chairman and Chief Executive Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Prior to Trimaran, Mr. Kehler was a Managing Director and Vice Chairman of CIBC, where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Kehler was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Kehler was a co-founder of Argosy. Prior to Argosy, Mr. Kehler was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Kehler currently serves on the Boards of Directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) and the boards of directors of El Pollo Loco and KCAP, respectively. Mr. Kehler has also served on the boards of many private and public companies spanning various industries. Mr. Kehler previously served as a Director, Treasurer and Chair of the Finance Committee of CARE USA, one of the world's largest private humanitarian organizations; and as Chair of the Board of Overseers of the University of Pennsylvania School of Nursing. Mr. Kehler graduated from the Wharton School of the University of Pennsylvania. - Dean C. Kehler，Gx Acquisition Corp. ii自成立以来担任联席主席兼首席执行官，是Trimaran的管理合伙人，他于1998年与他人共同创立了Trimaran基金II，并担任该基金的经理。2018年8月至2021年7月，他在GX Acquisition Corp.担任联席董事长兼首席执行官，GX Acquisition Corp.是一家与Celularity Inc.合并的特殊目的收购公司。在Trimaran之前，Kehler先生是CIBC的董事总经理兼副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆融资业务，这些业务包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生目前分别在Celularity（生物技术股票代码：CELU）董事会以及El Pollo Loco和KCAP董事会任职。凯勒先生还曾在许多跨越各个行业的私营和上市公司的董事会任职。Kehler先生曾担任世界上最大的私营人道主义组织之一的CARE USA的主任、财务主任和财务委员会主席；以及宾夕法尼亚大学护理学院监督委员会主席。Kehler先生毕业于宾夕法尼亚大学沃顿商学院。
- Dean C. Kehler, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran, which he co-founded in 1998, and serves as a Manager of Trimaran Fund II. From August 2018 to July 2021, he served as Co-Chairman and Chief Executive Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Prior to Trimaran, Mr. Kehler was a Managing Director and Vice Chairman of CIBC, where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Kehler was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Kehler was a co-founder of Argosy. Prior to Argosy, Mr. Kehler was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Kehler currently serves on the Boards of Directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) and the boards of directors of El Pollo Loco and KCAP, respectively. Mr. Kehler has also served on the boards of many private and public companies spanning various industries. Mr. Kehler previously served as a Director, Treasurer and Chair of the Finance Committee of CARE USA, one of the world's largest private humanitarian organizations; and as Chair of the Board of Overseers of the University of Pennsylvania School of Nursing. Mr. Kehler graduated from the Wharton School of the University of Pennsylvania.
- Hillel Weinberger
-
Hillel Weinberger，自2021年2月起担任Gx Acquisition Corp. ii的董事之一，自2010年起担任私人风险投资公司HLA的负责人。在此之前，2007年至今，Weinberger先生一直是Hillmark Capital Management，L.P.的联合创始人，在此之前，1988年至2006年担任财产和意外伤害保险公司Loews/CNA控股公司的高级副总裁。在此之前，他曾于1982年至1988年担任总统生活部高级副总裁。1997年至2000年，他在Global Crossing Ltd.（电信，纽约证券交易所代码：GX）董事会任职，担任审计委员会主席；1990年至1993年，他在News Communications，Inc.（报纸和杂志出版）董事会任职。Weinberger先生曾就读于坦普尔大学和Benjamin N. Cardozo法学院。
Hillel Weinberger, one of Gx Acquisition Corp. Ii directors since February 2021, has since 2010 been a Principal of HLA, a privately-owned venture capital firm. Prior to this, from 2007 to the present, Mr. Weinberger has been co-founder of Hillmark Capital Management, L.P., and before this was a Senior Vice-President of Loews/CNA Holdings, a property and casualty insurance company, from 1988 to 2006. Prior thereto he was a Senior Vice-President of Presidential Life, from 1982 to1988. He has served on the boards of Global Crossing Ltd. (telecommunications; NYSE: GX) from 1997 to 2000, where he chaired the Audit Committee, and News Communications, Inc. (newspaper and magazine publishing) from 1990 to1993. Mr. Weinberger attended Temple University and the Benjamin N. Cardozo School of Law. - Hillel Weinberger，自2021年2月起担任Gx Acquisition Corp. ii的董事之一，自2010年起担任私人风险投资公司HLA的负责人。在此之前，2007年至今，Weinberger先生一直是Hillmark Capital Management，L.P.的联合创始人，在此之前，1988年至2006年担任财产和意外伤害保险公司Loews/CNA控股公司的高级副总裁。在此之前，他曾于1982年至1988年担任总统生活部高级副总裁。1997年至2000年，他在Global Crossing Ltd.（电信，纽约证券交易所代码：GX）董事会任职，担任审计委员会主席；1990年至1993年，他在News Communications，Inc.（报纸和杂志出版）董事会任职。Weinberger先生曾就读于坦普尔大学和Benjamin N. Cardozo法学院。
- Hillel Weinberger, one of Gx Acquisition Corp. Ii directors since February 2021, has since 2010 been a Principal of HLA, a privately-owned venture capital firm. Prior to this, from 2007 to the present, Mr. Weinberger has been co-founder of Hillmark Capital Management, L.P., and before this was a Senior Vice-President of Loews/CNA Holdings, a property and casualty insurance company, from 1988 to 2006. Prior thereto he was a Senior Vice-President of Presidential Life, from 1982 to1988. He has served on the boards of Global Crossing Ltd. (telecommunications; NYSE: GX) from 1997 to 2000, where he chaired the Audit Committee, and News Communications, Inc. (newspaper and magazine publishing) from 1990 to1993. Mr. Weinberger attended Temple University and the Benjamin N. Cardozo School of Law.
- Marc Mazur
-
Marc Mazur，自2021年2月起担任Gx Acquisition Corp. ii的董事之一，自2014年起担任私人债务基金Brightwood Capital Advisors，LLC的行业顾问。从2006年到2008年，Mazur先生担任总部设在伦敦的全球宏观对冲基金Brevan Howard U.S. Asset Management的首席执行官，并在2010年之前担任该公司的高级顾问。2010年至2019年12月，Mazur先生担任Fibrocell Science, Inc.（Nasdaq：FCSC）的董事会成员，该公司是一家自体细胞和基因治疗公司。Mazur先生还曾担任Sutter Rock Capital（Nasdaq：SSSS）审计委员会主席和估值委员会成员，Sutter Rock Capital是一家商业发展公司，自2017年起对后期风险投资支持的私营公司进行投资。2001年至2005年，他担任清华创投的高级顾问。Mazur先生于1984年至1987年在所罗门兄弟公司担任副总裁，于1987年至1996年在高盛集团（“高盛”）固定收益部担任副总裁，并于1997年至1999年担任高盛的顾问。在2010年至2014年期间，他担任Staywell Health的董事和DeVilbiss Health的董事，该公司是健康和医疗设备领域的私营公司。Mazur先生在哥伦比亚大学获得政治学学士学位，在维拉诺瓦大学法学院获得法学博士学位。
Marc Mazur, one of Gx Acquisition Corp. Ii directors since February 2021, has served as an Industry Advisor for Brightwood Capital Advisors, LLC, a private debt fund, since 2014. From 2006 until 2008, Mr. Mazur served as the Chief Executive Officer of Brevan Howard U.S. Asset Management, a London-based global macro hedge fund, and a senior advisor of this company until 2010. From 2010 through December 2019, Mr. Mazur has served as a member of the board of directors for Fibrocell Science, Inc. (Nasdaq: FCSC), an autologous cell and gene therapy company. Mr. Mazur also served as chairman of the audit committee and a member of the valuation committee of Sutter Rock Capital (Nasdaq: SSSS), a business development company that invests in late-stage venture-backed private companies since 2017. He served a senior advisor to Tsinghua Venture Capital from 2001 to 2005. Mr. Mazur served as a Vice President at Salomon Brothers, Inc from 1984 to 1987 and served as a Vice President in the Fixed Income Division of The Goldman Sachs Group, Inc. ("Goldman") from 1987 until 1996, and served as a consultant for Goldman from 1997 to 1999. Between 2010 and 2014, he served as a director of Staywell Health and as a director of DeVilbiss Health, private companies in the wellness and medical device fields. Mr. Mazur received his B.A. in Political Science from Columbia University and a J.D. from Villanova University School of Law. - Marc Mazur，自2021年2月起担任Gx Acquisition Corp. ii的董事之一，自2014年起担任私人债务基金Brightwood Capital Advisors，LLC的行业顾问。从2006年到2008年，Mazur先生担任总部设在伦敦的全球宏观对冲基金Brevan Howard U.S. Asset Management的首席执行官，并在2010年之前担任该公司的高级顾问。2010年至2019年12月，Mazur先生担任Fibrocell Science, Inc.（Nasdaq：FCSC）的董事会成员，该公司是一家自体细胞和基因治疗公司。Mazur先生还曾担任Sutter Rock Capital（Nasdaq：SSSS）审计委员会主席和估值委员会成员，Sutter Rock Capital是一家商业发展公司，自2017年起对后期风险投资支持的私营公司进行投资。2001年至2005年，他担任清华创投的高级顾问。Mazur先生于1984年至1987年在所罗门兄弟公司担任副总裁，于1987年至1996年在高盛集团（“高盛”）固定收益部担任副总裁，并于1997年至1999年担任高盛的顾问。在2010年至2014年期间，他担任Staywell Health的董事和DeVilbiss Health的董事，该公司是健康和医疗设备领域的私营公司。Mazur先生在哥伦比亚大学获得政治学学士学位，在维拉诺瓦大学法学院获得法学博士学位。
- Marc Mazur, one of Gx Acquisition Corp. Ii directors since February 2021, has served as an Industry Advisor for Brightwood Capital Advisors, LLC, a private debt fund, since 2014. From 2006 until 2008, Mr. Mazur served as the Chief Executive Officer of Brevan Howard U.S. Asset Management, a London-based global macro hedge fund, and a senior advisor of this company until 2010. From 2010 through December 2019, Mr. Mazur has served as a member of the board of directors for Fibrocell Science, Inc. (Nasdaq: FCSC), an autologous cell and gene therapy company. Mr. Mazur also served as chairman of the audit committee and a member of the valuation committee of Sutter Rock Capital (Nasdaq: SSSS), a business development company that invests in late-stage venture-backed private companies since 2017. He served a senior advisor to Tsinghua Venture Capital from 2001 to 2005. Mr. Mazur served as a Vice President at Salomon Brothers, Inc from 1984 to 1987 and served as a Vice President in the Fixed Income Division of The Goldman Sachs Group, Inc. ("Goldman") from 1987 until 1996, and served as a consultant for Goldman from 1997 to 1999. Between 2010 and 2014, he served as a director of Staywell Health and as a director of DeVilbiss Health, private companies in the wellness and medical device fields. Mr. Mazur received his B.A. in Political Science from Columbia University and a J.D. from Villanova University School of Law.
- James W. Harpel
-
James W. Harpel，自2021年2月起担任Gx Acquisition Corp. ii的董事之一，是Two Roads Development的联合创始人，该公司是一家房地产开发公司，在佛罗里达州从事以住宅为主的重建项目的规划和开发。Harpel先生负责公司的一般监督，并担任公司投资委员会主席。1984年，他与人共同创立了First Reserve公司，并担任其普通合伙人。该公司管理着一系列私募股权基金，从事能源、电力和相关的基础设施业务。从2003年到2020年，Harpel先生是Palm Beach Capital的普通合伙人，该公司投资和建立中小型公司，并直接进行房地产投资。Harpel先生也是一位积极的企业家和个人利益，并为一系列生物技术、医疗相关和工业公司提供咨询。Harpel先生在哈佛大学肯尼迪学院董事会任职40多年，目前是肯尼迪学院贝尔弗中心董事会成员。他还曾在Dana Farber癌症研究所董事会任职。哈佩尔先生在肯尼迪学校有一个捐赠的教席。他目前是西棕榈滩克拉维斯中心执行委员会的成员，也是外交关系委员会的成员。此外，Harpel先生还获得了2019年埃利斯岛荣誉勋章。哈佩尔先生就读于哈佛大学（1959年），1960年以优异成绩毕业于哈佛商学院。
James W. Harpel, one of Gx Acquisition Corp. Ii directors since February 2021, is a Co-Founder of Two Roads Development, a real estate development company involved in the planning and development of largely residential restate in the State of Florida. Mr. Harpel is responsible for the general oversight of the firm and chairs the Investment Committee for the Company. In 1984 he co-founded and currently serves as a general partner of First Reserve Corporation, which has managed a series of private equity funds, in the energy, power and related infrastructure businesses. From 2003 until 2020, Mr. Harpel was a General Partner of Palm Beach Capital, which invests in and builds small and medium sized companies and makes direct real estate investments. Mr. Harpel is also an active entrepreneur and own interests and consults to a series of biotech, medically related and industrial companies. Mr. Harpel served on the Board of the Kennedy School at Harvard for over 40 years and is currently a member of the Board of Directors at the Belfer Center at the Kennedy School. He also served on the Dana Farber Cancer Institute Board. Mr. Harpel has an Endowed Chair at the Kennedy School. He is currently on the Executive Committee of the Kravis Center in West Palm Beach, and is also a member of the Council on Foreign Relations. In addition, Mr. Harpel is a recipient of the 2019 Ellis Island Medal of Honor. Mr. Harpel attended Harvard College (1959) and graduated from Harvard Business School in 1960 with high distinction. - James W. Harpel，自2021年2月起担任Gx Acquisition Corp. ii的董事之一，是Two Roads Development的联合创始人，该公司是一家房地产开发公司，在佛罗里达州从事以住宅为主的重建项目的规划和开发。Harpel先生负责公司的一般监督，并担任公司投资委员会主席。1984年，他与人共同创立了First Reserve公司，并担任其普通合伙人。该公司管理着一系列私募股权基金，从事能源、电力和相关的基础设施业务。从2003年到2020年，Harpel先生是Palm Beach Capital的普通合伙人，该公司投资和建立中小型公司，并直接进行房地产投资。Harpel先生也是一位积极的企业家和个人利益，并为一系列生物技术、医疗相关和工业公司提供咨询。Harpel先生在哈佛大学肯尼迪学院董事会任职40多年，目前是肯尼迪学院贝尔弗中心董事会成员。他还曾在Dana Farber癌症研究所董事会任职。哈佩尔先生在肯尼迪学校有一个捐赠的教席。他目前是西棕榈滩克拉维斯中心执行委员会的成员，也是外交关系委员会的成员。此外，Harpel先生还获得了2019年埃利斯岛荣誉勋章。哈佩尔先生就读于哈佛大学（1959年），1960年以优异成绩毕业于哈佛商学院。
- James W. Harpel, one of Gx Acquisition Corp. Ii directors since February 2021, is a Co-Founder of Two Roads Development, a real estate development company involved in the planning and development of largely residential restate in the State of Florida. Mr. Harpel is responsible for the general oversight of the firm and chairs the Investment Committee for the Company. In 1984 he co-founded and currently serves as a general partner of First Reserve Corporation, which has managed a series of private equity funds, in the energy, power and related infrastructure businesses. From 2003 until 2020, Mr. Harpel was a General Partner of Palm Beach Capital, which invests in and builds small and medium sized companies and makes direct real estate investments. Mr. Harpel is also an active entrepreneur and own interests and consults to a series of biotech, medically related and industrial companies. Mr. Harpel served on the Board of the Kennedy School at Harvard for over 40 years and is currently a member of the Board of Directors at the Belfer Center at the Kennedy School. He also served on the Dana Farber Cancer Institute Board. Mr. Harpel has an Endowed Chair at the Kennedy School. He is currently on the Executive Committee of the Kravis Center in West Palm Beach, and is also a member of the Council on Foreign Relations. In addition, Mr. Harpel is a recipient of the 2019 Ellis Island Medal of Honor. Mr. Harpel attended Harvard College (1959) and graduated from Harvard Business School in 1960 with high distinction.
- Dean C. Kehler
-
Dean C. Kehler，自成立以来一直担任Celularity公司董事会成员。Kehler先生还是Trimaran的管理合伙人，Trimaran由他于1998年与他人共同创立，担任Trimaran Fund II的管理人，并担任GX Acquisition Corp. II（纳斯达克：GXII）的联席董事长兼首席执行官和董事。Kehler先生自2023年3月起担任NioCorp Developments Ltd.（纳斯达克：NB）的董事。于2005年11月至2023年3月期间，他担任El Pollo Loco Holdings, Inc.（餐厅；纳斯达克：LOCO）的董事。在加入Trimaran之前，Kehler先生是CIBC的董事总经理和副主席，负责CIBC在美国和欧洲的商业银行活动，这些活动是通过CIBC基金进行的。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆金融业务，其中包括财务发起人覆盖；收购融资；高收益发起、承销、销售和交易；私募；以及财务重组咨询服务。在加入CIBC之前，Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生在Portman Ridge Finance Corporation的董事会任职。（投资公司；纳斯达克：PTMN）和Security First Corp.（网络安全和数据管理软件），他是该公司的副董事长。他还担任宾夕法尼亚大学护理学院监督委员会成员，曾任主席。在过去五年内，他曾担任Inviva Inc.（保险）、Graphene Frontiers，LLC（石墨烯）的董事。Kehler先生此前曾担任Ashley Stewart Holdings，Inc.（零售）；Continental Airlines Inc.（航空公司；NYSE：CAL）；Global Crossing Ltd.（电信；NYSE：GX）；Hills Department Stores，Inc.（零售；NYSE：HDS）；TeleBanc Financial Corp.（互联网银行；纳斯达克：TBFC）；Booth Creek Ski Group，Inc.（房地产；休闲）；CB Holding Corp.（餐饮）；CNC Holding Corp.（零售）；Heating Oil Partners，L.P.（能源）；Jefferson National Financial Corporation（annuities）；PrimeCo Wireless Communications，LLC（通信）；Source Financing Corp.（零售）；TLC Beatrice International Inc.（消费产品）；和Urban Brands，此外，Kehler先生此前还曾担任ITC控股，Inc.（电力传动）的董事会观察员。Kehler先生此前曾担任CARE USA的董事、财务主管和财务委员会主席，CARE USA是世界上最大的私营人道主义组织之一。Kehler先生毕业于Pennsylvania大学Wharton商学院。
Dean C. Kehler,serves on the Compensation Committee of the Board. Mr. Kehler is a Managing Partner of Trimaran Capital Partners, a manager of private investment funds. Prior to co-founding Trimaran, Mr. Kehler was a vice chairman of CIBC World Markets Corp. and co-head of the CIBC Argosy Merchant Banking Funds. Prior to joining CIBC World Markets Corp. in 1995, Mr. Kehler was a founder and Managing Director of The Argosy Group L.P. Before Argosy, Mr. Kehler was a Managing Director at Drexel Burnham Lambert Incorporated and also worked at Lehman Brothers Kuhn Loeb Incorporated. Mr. Kehler currently serves on the Boards of Directors of Celularity Inc. and NioCorp Developments Ltd. Mr. Kehler previously served as a director of various public and private companies. Mr. Kehler earned his B.S. from The Wharton School of the University of Pennsylvania. - Dean C. Kehler，自成立以来一直担任Celularity公司董事会成员。Kehler先生还是Trimaran的管理合伙人，Trimaran由他于1998年与他人共同创立，担任Trimaran Fund II的管理人，并担任GX Acquisition Corp. II（纳斯达克：GXII）的联席董事长兼首席执行官和董事。Kehler先生自2023年3月起担任NioCorp Developments Ltd.（纳斯达克：NB）的董事。于2005年11月至2023年3月期间，他担任El Pollo Loco Holdings, Inc.（餐厅；纳斯达克：LOCO）的董事。在加入Trimaran之前，Kehler先生是CIBC的董事总经理和副主席，负责CIBC在美国和欧洲的商业银行活动，这些活动是通过CIBC基金进行的。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆金融业务，其中包括财务发起人覆盖；收购融资；高收益发起、承销、销售和交易；私募；以及财务重组咨询服务。在加入CIBC之前，Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生在Portman Ridge Finance Corporation的董事会任职。（投资公司；纳斯达克：PTMN）和Security First Corp.（网络安全和数据管理软件），他是该公司的副董事长。他还担任宾夕法尼亚大学护理学院监督委员会成员，曾任主席。在过去五年内，他曾担任Inviva Inc.（保险）、Graphene Frontiers，LLC（石墨烯）的董事。Kehler先生此前曾担任Ashley Stewart Holdings，Inc.（零售）；Continental Airlines Inc.（航空公司；NYSE：CAL）；Global Crossing Ltd.（电信；NYSE：GX）；Hills Department Stores，Inc.（零售；NYSE：HDS）；TeleBanc Financial Corp.（互联网银行；纳斯达克：TBFC）；Booth Creek Ski Group，Inc.（房地产；休闲）；CB Holding Corp.（餐饮）；CNC Holding Corp.（零售）；Heating Oil Partners，L.P.（能源）；Jefferson National Financial Corporation（annuities）；PrimeCo Wireless Communications，LLC（通信）；Source Financing Corp.（零售）；TLC Beatrice International Inc.（消费产品）；和Urban Brands，此外，Kehler先生此前还曾担任ITC控股，Inc.（电力传动）的董事会观察员。Kehler先生此前曾担任CARE USA的董事、财务主管和财务委员会主席，CARE USA是世界上最大的私营人道主义组织之一。Kehler先生毕业于Pennsylvania大学Wharton商学院。
- Dean C. Kehler,serves on the Compensation Committee of the Board. Mr. Kehler is a Managing Partner of Trimaran Capital Partners, a manager of private investment funds. Prior to co-founding Trimaran, Mr. Kehler was a vice chairman of CIBC World Markets Corp. and co-head of the CIBC Argosy Merchant Banking Funds. Prior to joining CIBC World Markets Corp. in 1995, Mr. Kehler was a founder and Managing Director of The Argosy Group L.P. Before Argosy, Mr. Kehler was a Managing Director at Drexel Burnham Lambert Incorporated and also worked at Lehman Brothers Kuhn Loeb Incorporated. Mr. Kehler currently serves on the Boards of Directors of Celularity Inc. and NioCorp Developments Ltd. Mr. Kehler previously served as a director of various public and private companies. Mr. Kehler earned his B.S. from The Wharton School of the University of Pennsylvania.
- Jay R. Bloom
-
Jay R. Bloom，他于2012年2月加入KCAP Financial公司的董事会。他也是Trimaran Advisors公司（公司于2012年2月收购的公司）的投资组合经理，任职于投资委员会，并担任几个证券基金投资顾问。他也是Trimaran Capital Partners公司的管理合伙人，以及私人投资基金的经理。他曾是CIBC World Markets Corp公司的副主席，以及the CIBC Argosy Merchant Banking Funds的联席主管。他曾于1995年加入CIBC World Markets公司。他是The Argosy集团的创始人兼董事总经理。他曾担任德崇证券（Drexel Burnham Lambert Incorporated）的董事总经理。他也曾任职雷曼兄弟（Lehman Brothers Kuhn Loeb Incorporated）公司。此外，他在Paul Weiss Rifkind Wharton & Garrison进行法律实践。他目前任职于Brite Media、 Educational Services of America、El Pollo Loco和Norcraft Companies公司的董事会。他获得康奈尔大学（Cornell University）的学士学位和工商管理硕士学位，以及哥伦比亚大学法学院（Columbia University School of Law）法学博士学位。他是哥伦比亚大学《法律评论》的编辑。
Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review. - Jay R. Bloom，他于2012年2月加入KCAP Financial公司的董事会。他也是Trimaran Advisors公司（公司于2012年2月收购的公司）的投资组合经理，任职于投资委员会，并担任几个证券基金投资顾问。他也是Trimaran Capital Partners公司的管理合伙人，以及私人投资基金的经理。他曾是CIBC World Markets Corp公司的副主席，以及the CIBC Argosy Merchant Banking Funds的联席主管。他曾于1995年加入CIBC World Markets公司。他是The Argosy集团的创始人兼董事总经理。他曾担任德崇证券（Drexel Burnham Lambert Incorporated）的董事总经理。他也曾任职雷曼兄弟（Lehman Brothers Kuhn Loeb Incorporated）公司。此外，他在Paul Weiss Rifkind Wharton & Garrison进行法律实践。他目前任职于Brite Media、 Educational Services of America、El Pollo Loco和Norcraft Companies公司的董事会。他获得康奈尔大学（Cornell University）的学士学位和工商管理硕士学位，以及哥伦比亚大学法学院（Columbia University School of Law）法学博士学位。他是哥伦比亚大学《法律评论》的编辑。
- Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review.
高管简历
中英对照 | 中文 | 英文- Andrea J. Kellett
AndreaJ.Kellett自成立以来一直是我们的首席财务官，自2006年以来一直担任Trimaran的董事总经理兼首席财务官。Kellett女士负责会计、管理和财务报告、人力资源和行政事务。加入Trimaran公司之前，她曾担任CIBC公司的杠杆金融集团的执行董事，也曾担任Argosy公司（她于1990年加入该公司）的总会计师。在加入Argosy之前，Kellett女士是Thomson McKinnon Securities，Inc.房地产避税部门的Vice President。Kellett女士的职业生涯始于担任Arthur Young&Co.的审计师。Kellett女士在纽约州立大学奥尔巴尼分校（State University of New York at Albany）商学院获得工商管理学士学位。
Andrea J. Kellett, Gx Acquisition Corp. Ii Chief Financial Officer since inception, has been a Managing Director and the Chief Financial Officer of Trimaran since June 2000. From August 2018 to July 2021, she served as Chief Financial Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Mrs. Kellett is responsible for accounting, management and financial reporting, human resources and administrative matters. Prior to joining Trimaran, Mrs. Kellett was an Executive Director in the Leveraged Finance Group of CIBC and was the Controller of Argosy, which she joined in 1990. Prior to joining Argosy, Mrs. Kellett was a Vice President in the Real Estate Tax Shelter Department of Thomson McKinnon Securities, Inc. Mrs. Kellett began her career as an auditor for Arthur Young & Co. Mrs. Kellett received her B.S. from the School of Business at the State University of New York at Albany.- AndreaJ.Kellett自成立以来一直是我们的首席财务官，自2006年以来一直担任Trimaran的董事总经理兼首席财务官。Kellett女士负责会计、管理和财务报告、人力资源和行政事务。加入Trimaran公司之前，她曾担任CIBC公司的杠杆金融集团的执行董事，也曾担任Argosy公司（她于1990年加入该公司）的总会计师。在加入Argosy之前，Kellett女士是Thomson McKinnon Securities，Inc.房地产避税部门的Vice President。Kellett女士的职业生涯始于担任Arthur Young&Co.的审计师。Kellett女士在纽约州立大学奥尔巴尼分校（State University of New York at Albany）商学院获得工商管理学士学位。
- Andrea J. Kellett, Gx Acquisition Corp. Ii Chief Financial Officer since inception, has been a Managing Director and the Chief Financial Officer of Trimaran since June 2000. From August 2018 to July 2021, she served as Chief Financial Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Mrs. Kellett is responsible for accounting, management and financial reporting, human resources and administrative matters. Prior to joining Trimaran, Mrs. Kellett was an Executive Director in the Leveraged Finance Group of CIBC and was the Controller of Argosy, which she joined in 1990. Prior to joining Argosy, Mrs. Kellett was a Vice President in the Real Estate Tax Shelter Department of Thomson McKinnon Securities, Inc. Mrs. Kellett began her career as an auditor for Arthur Young & Co. Mrs. Kellett received her B.S. from the School of Business at the State University of New York at Albany.
- Jay R. Bloom
Jay R. Bloom自成立以来一直担任Gx Acquisition Corp. ii的联席主席兼首席执行官，是Trimaran Fund Management，L.L.C. d/b/a Trimaran Capital Partners（“Trimaran”）的管理合伙人，他于1998年与他人共同创立了Trimaran Capital Partners（“Trimaran”），并担任现有的私募股权基金Trimaran Fund II的经理。Trimaran及其附属实体管理着私人股本基金、抵押贷款债务和对冲基金（就对冲基金而言，作为次级顾问）。在加入Trimaran之前，Bloom先生是CIBC World Markets Corp.（“CIBC”）的董事总经理和副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，布卢姆还负责监管CIBC在美国和欧洲的杠杆融资业务，包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Bloom先生是The Argosy Group，LP（“Argosy”）的联合创始人，该公司是一家从事杠杆融资活动和本金投资的精品投资银行。Argosy于1995年被CIBC收购。在Argosy之前，布卢姆是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。布卢姆还在Paul Weiss Rifkind Wharton & Garrison从事法律工作。Bloom先生自2021年7月起担任Celularity（生物科技；纳斯达克股票代码：CELU）的董事会成员。布卢姆还曾在多个不同行业的私营和上市公司的董事会任职。他曾在哥伦比亚大学里奇曼商业、法律和公共政策中心顾问委员会任职，是康奈尔大学理事会和康奈尔大学本科生商业项目顾问委员会的成员，并且是康奈尔大学约翰逊管理研究生院顾问委员会的名誉成员。Bloom先生以优异成绩毕业于康奈尔大学，获得学士学位，毕业于约翰逊研究生院，获得工商管理硕士学位，毕业于哥伦比亚大学法学院，获得法学博士学位，并担任《哥伦比亚法律评论》编辑委员会成员。
Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review.- Jay R. Bloom自成立以来一直担任Gx Acquisition Corp. ii的联席主席兼首席执行官，是Trimaran Fund Management，L.L.C. d/b/a Trimaran Capital Partners（“Trimaran”）的管理合伙人，他于1998年与他人共同创立了Trimaran Capital Partners（“Trimaran”），并担任现有的私募股权基金Trimaran Fund II的经理。Trimaran及其附属实体管理着私人股本基金、抵押贷款债务和对冲基金（就对冲基金而言，作为次级顾问）。在加入Trimaran之前，Bloom先生是CIBC World Markets Corp.（“CIBC”）的董事总经理和副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，布卢姆还负责监管CIBC在美国和欧洲的杠杆融资业务，包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Bloom先生是The Argosy Group，LP（“Argosy”）的联合创始人，该公司是一家从事杠杆融资活动和本金投资的精品投资银行。Argosy于1995年被CIBC收购。在Argosy之前，布卢姆是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。布卢姆还在Paul Weiss Rifkind Wharton & Garrison从事法律工作。Bloom先生自2021年7月起担任Celularity（生物科技；纳斯达克股票代码：CELU）的董事会成员。布卢姆还曾在多个不同行业的私营和上市公司的董事会任职。他曾在哥伦比亚大学里奇曼商业、法律和公共政策中心顾问委员会任职，是康奈尔大学理事会和康奈尔大学本科生商业项目顾问委员会的成员，并且是康奈尔大学约翰逊管理研究生院顾问委员会的名誉成员。Bloom先生以优异成绩毕业于康奈尔大学，获得学士学位，毕业于约翰逊研究生院，获得工商管理硕士学位，毕业于哥伦比亚大学法学院，获得法学博士学位，并担任《哥伦比亚法律评论》编辑委员会成员。
- Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review.
- Dean C. Kehler
Dean C. Kehler，Gx Acquisition Corp. ii自成立以来担任联席主席兼首席执行官，是Trimaran的管理合伙人，他于1998年与他人共同创立了Trimaran基金II，并担任该基金的经理。2018年8月至2021年7月，他在GX Acquisition Corp.担任联席董事长兼首席执行官，GX Acquisition Corp.是一家与Celularity Inc.合并的特殊目的收购公司。在Trimaran之前，Kehler先生是CIBC的董事总经理兼副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆融资业务，这些业务包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生目前分别在Celularity（生物技术股票代码：CELU）董事会以及El Pollo Loco和KCAP董事会任职。凯勒先生还曾在许多跨越各个行业的私营和上市公司的董事会任职。Kehler先生曾担任世界上最大的私营人道主义组织之一的CARE USA的主任、财务主任和财务委员会主席；以及宾夕法尼亚大学护理学院监督委员会主席。Kehler先生毕业于宾夕法尼亚大学沃顿商学院。
Dean C. Kehler, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran, which he co-founded in 1998, and serves as a Manager of Trimaran Fund II. From August 2018 to July 2021, he served as Co-Chairman and Chief Executive Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Prior to Trimaran, Mr. Kehler was a Managing Director and Vice Chairman of CIBC, where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Kehler was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Kehler was a co-founder of Argosy. Prior to Argosy, Mr. Kehler was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Kehler currently serves on the Boards of Directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) and the boards of directors of El Pollo Loco and KCAP, respectively. Mr. Kehler has also served on the boards of many private and public companies spanning various industries. Mr. Kehler previously served as a Director, Treasurer and Chair of the Finance Committee of CARE USA, one of the world's largest private humanitarian organizations; and as Chair of the Board of Overseers of the University of Pennsylvania School of Nursing. Mr. Kehler graduated from the Wharton School of the University of Pennsylvania.- Dean C. Kehler，Gx Acquisition Corp. ii自成立以来担任联席主席兼首席执行官，是Trimaran的管理合伙人，他于1998年与他人共同创立了Trimaran基金II，并担任该基金的经理。2018年8月至2021年7月，他在GX Acquisition Corp.担任联席董事长兼首席执行官，GX Acquisition Corp.是一家与Celularity Inc.合并的特殊目的收购公司。在Trimaran之前，Kehler先生是CIBC的董事总经理兼副主席，负责CIBC通过CIBC基金开展的美国和欧洲商业银行业务。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆融资业务，这些业务包括财务赞助、收购融资、高收益发行、承销、销售和交易、私募和财务重组咨询服务。Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生目前分别在Celularity（生物技术股票代码：CELU）董事会以及El Pollo Loco和KCAP董事会任职。凯勒先生还曾在许多跨越各个行业的私营和上市公司的董事会任职。Kehler先生曾担任世界上最大的私营人道主义组织之一的CARE USA的主任、财务主任和财务委员会主席；以及宾夕法尼亚大学护理学院监督委员会主席。Kehler先生毕业于宾夕法尼亚大学沃顿商学院。
- Dean C. Kehler, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran, which he co-founded in 1998, and serves as a Manager of Trimaran Fund II. From August 2018 to July 2021, he served as Co-Chairman and Chief Executive Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Prior to Trimaran, Mr. Kehler was a Managing Director and Vice Chairman of CIBC, where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Kehler was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Kehler was a co-founder of Argosy. Prior to Argosy, Mr. Kehler was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Kehler currently serves on the Boards of Directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) and the boards of directors of El Pollo Loco and KCAP, respectively. Mr. Kehler has also served on the boards of many private and public companies spanning various industries. Mr. Kehler previously served as a Director, Treasurer and Chair of the Finance Committee of CARE USA, one of the world's largest private humanitarian organizations; and as Chair of the Board of Overseers of the University of Pennsylvania School of Nursing. Mr. Kehler graduated from the Wharton School of the University of Pennsylvania.
- Michael G. Maselli
Michael G. Maselli自Gx Acquisition Corp. ii成立以来一直担任总裁，自2006年起担任Trimaran的董事总经理。2018年8月至2021年7月，他在GX Acquisition Corp.收购公司担任副总裁，该公司是一家与Celularity Inc.合并的特殊目的收购公司。在加入Trimaran之前，Maselli先生曾在加拿大帝国商业银行企业集团和杠杆金融集团工作。在1997年加入加拿大帝国商业银行之前，Maselli先生曾在贝尔斯登的公司融资部门担任董事总经理，在此之前，在Kidder Peabody & Co. Incorporated担任副总裁。Maselli先生作为董事或顾问指导公司及其董事会超过30年。Maselli先生自2011年起担任El Pollo Loco控股公司（Nasdaq：LOCO）的董事会主席，该公司从事餐饮业。2013年至2015年，他在Norcraft Companies, Inc.董事会任职，并于2003年开始在其前身公司董事会任职。此外，Maselli先生还在ChanceLight，Inc.（f/k/a Educational Services of America，Inc.）、Brite Media Group，Inc.和Standard Steel，LLC的董事会任职，并担任CB Holding Corp.的董事和主席。Maselli先生以优异的成绩获得杜兰大学A.B. Freeman学院的工商管理硕士学位和科罗拉多大学的经济学学士学位。
Michael G. Maselli, Gx Acquisition Corp. Ii President since inception, has been a Managing Director of Trimaran since 2006. From August 2018 to July 2021, he has served as Vice President of Acquisitions of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Before joining Trimaran, Mr. Maselli worked in the Corporate and Leverage Finance Groups of CIBC. Prior to joining CIBC in 1997, Mr. Maselli served as a Managing Director in Bear Stearns' corporate finance group and, prior to that, as a Vice President at Kidder Peabody & Co. Incorporated. Mr. Maselli has guided companies and their boards as a director or advisor for over 30 years. Since 2011, Mr. Maselli has served as the Chairman of the Board of El Pollo Loco Holdings Inc. (Nasdaq: LOCO), a company engaged in the restaurant industry. From 2013 to 2015, he served on the board of directors of Norcraft Companies, Inc., and served on the board of managers of its predecessor company beginning in 2003. Additionally, Mr. Maselli served on the board of directors of ChanceLight, Inc. (f/k/a Educational Services of America, Inc.), Brite Media Group, Inc. and Standard Steel, LLC, and was director as well as Chairman of the Board of CB Holding Corp. Mr. Maselli received an MBA with distinction from The A.B. Freeman School at Tulane University and a bachelor's degree in economics from the University of Colorado.- Michael G. Maselli自Gx Acquisition Corp. ii成立以来一直担任总裁，自2006年起担任Trimaran的董事总经理。2018年8月至2021年7月，他在GX Acquisition Corp.收购公司担任副总裁，该公司是一家与Celularity Inc.合并的特殊目的收购公司。在加入Trimaran之前，Maselli先生曾在加拿大帝国商业银行企业集团和杠杆金融集团工作。在1997年加入加拿大帝国商业银行之前，Maselli先生曾在贝尔斯登的公司融资部门担任董事总经理，在此之前，在Kidder Peabody & Co. Incorporated担任副总裁。Maselli先生作为董事或顾问指导公司及其董事会超过30年。Maselli先生自2011年起担任El Pollo Loco控股公司（Nasdaq：LOCO）的董事会主席，该公司从事餐饮业。2013年至2015年，他在Norcraft Companies, Inc.董事会任职，并于2003年开始在其前身公司董事会任职。此外，Maselli先生还在ChanceLight，Inc.（f/k/a Educational Services of America，Inc.）、Brite Media Group，Inc.和Standard Steel，LLC的董事会任职，并担任CB Holding Corp.的董事和主席。Maselli先生以优异的成绩获得杜兰大学A.B. Freeman学院的工商管理硕士学位和科罗拉多大学的经济学学士学位。
- Michael G. Maselli, Gx Acquisition Corp. Ii President since inception, has been a Managing Director of Trimaran since 2006. From August 2018 to July 2021, he has served as Vice President of Acquisitions of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Before joining Trimaran, Mr. Maselli worked in the Corporate and Leverage Finance Groups of CIBC. Prior to joining CIBC in 1997, Mr. Maselli served as a Managing Director in Bear Stearns' corporate finance group and, prior to that, as a Vice President at Kidder Peabody & Co. Incorporated. Mr. Maselli has guided companies and their boards as a director or advisor for over 30 years. Since 2011, Mr. Maselli has served as the Chairman of the Board of El Pollo Loco Holdings Inc. (Nasdaq: LOCO), a company engaged in the restaurant industry. From 2013 to 2015, he served on the board of directors of Norcraft Companies, Inc., and served on the board of managers of its predecessor company beginning in 2003. Additionally, Mr. Maselli served on the board of directors of ChanceLight, Inc. (f/k/a Educational Services of America, Inc.), Brite Media Group, Inc. and Standard Steel, LLC, and was director as well as Chairman of the Board of CB Holding Corp. Mr. Maselli received an MBA with distinction from The A.B. Freeman School at Tulane University and a bachelor's degree in economics from the University of Colorado.
- Andrea J. Kellett
Andrea J. Kellett，Gx Acquisition Corp. ii. Chief Financial Officer，自2000年6月起担任Trimaran的董事总经理兼Chief Financial Officer。2018年8月至2021年7月，她在GX Acquisition Corp.收购公司担任Chief Financial Officer。GX Acquisition Corp.是一家与Celularity Inc.合并的特殊目的收购公司。Kellett夫人负责会计、管理和财务报告、人力资源和行政事务。在加入Trimaran公司之前，Kellett女士是CIBC杠杆融资集团的执行董事，也是Argosy公司的财务总监，她于1990年加入该公司。在加入Argosy公司之前，Kellett夫人是Thomson McKinnon证券公司房地产避税处的副总裁。Kellett夫人的职业生涯始于Arthur Young & Co公司的审计员。Kellett夫人在奥尔巴尼的纽约州立大学商学院获得学士学位。
Andrea J. Kellett, Gx Acquisition Corp. Ii Chief Financial Officer since inception, has been a Managing Director and the Chief Financial Officer of Trimaran since June 2000. From August 2018 to July 2021, she served as Chief Financial Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Mrs. Kellett is responsible for accounting, management and financial reporting, human resources and administrative matters. Prior to joining Trimaran, Mrs. Kellett was an Executive Director in the Leveraged Finance Group of CIBC and was the Controller of Argosy, which she joined in 1990. Prior to joining Argosy, Mrs. Kellett was a Vice President in the Real Estate Tax Shelter Department of Thomson McKinnon Securities, Inc. Mrs. Kellett began her career as an auditor for Arthur Young & Co. Mrs. Kellett received her B.S. from the School of Business at the State University of New York at Albany.- Andrea J. Kellett，Gx Acquisition Corp. ii. Chief Financial Officer，自2000年6月起担任Trimaran的董事总经理兼Chief Financial Officer。2018年8月至2021年7月，她在GX Acquisition Corp.收购公司担任Chief Financial Officer。GX Acquisition Corp.是一家与Celularity Inc.合并的特殊目的收购公司。Kellett夫人负责会计、管理和财务报告、人力资源和行政事务。在加入Trimaran公司之前，Kellett女士是CIBC杠杆融资集团的执行董事，也是Argosy公司的财务总监，她于1990年加入该公司。在加入Argosy公司之前，Kellett夫人是Thomson McKinnon证券公司房地产避税处的副总裁。Kellett夫人的职业生涯始于Arthur Young & Co公司的审计员。Kellett夫人在奥尔巴尼的纽约州立大学商学院获得学士学位。
- Andrea J. Kellett, Gx Acquisition Corp. Ii Chief Financial Officer since inception, has been a Managing Director and the Chief Financial Officer of Trimaran since June 2000. From August 2018 to July 2021, she served as Chief Financial Officer of GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. Mrs. Kellett is responsible for accounting, management and financial reporting, human resources and administrative matters. Prior to joining Trimaran, Mrs. Kellett was an Executive Director in the Leveraged Finance Group of CIBC and was the Controller of Argosy, which she joined in 1990. Prior to joining Argosy, Mrs. Kellett was a Vice President in the Real Estate Tax Shelter Department of Thomson McKinnon Securities, Inc. Mrs. Kellett began her career as an auditor for Arthur Young & Co. Mrs. Kellett received her B.S. from the School of Business at the State University of New York at Albany.
- Arthur D. Baer
Arthur D. Baer，Gx Acquisition Corp. ii.自2021年2月起担任副总裁,2021年3月起担任Trimaran的投资专业人士，并担任GX Acquisition Corp.的顾问，GX Acquisition Corp.是一家特殊目的收购公司，于2018年8月至2021年7月与Celularity Inc.合并。此前，从2015年到2018年，他是卡文迪许基金管理公司的首席投资官，这是他创立的一家股票对冲基金。在加入卡文迪什之前，贝尔先生于2005年至2014年担任Brite Media Group LLC的Chief Financial Officer兼副主席。Brite Media Group是一家媒体和消费者营销公司，由Trimaran拥有多数股权。在Brite Media Group，Baer先生的职责包括收购、运营和业务规划，以及包括资本分配和会计在内的整体财务管理。他评估了Brite Media的数百个收购机会，这些机会导致完成了许多额外的收购，并管理了资产剥离过程，成功地在2012年将一个关键部门出售给了竞争对手，并在2014年将其他部门出售给了一家私人股本集团。Baer先生曾于2000年至2003年在雷曼兄弟公司工作，担任投资银行部门的分析师。Baer先生毕业于乔治敦大学，获得金融专业工商管理理学学士学位。
Arthur D. Baer, Gx Acquisition Corp. Ii Vice President since February 2021, is an investment professional at Trimaran since March 2021 and was a consultant to GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. from August 2018 to July 2021. Previously, from 2015 to 2018, he was Chief Investment Officer of Cavendish Fund Management LLC, an equity hedge fund that he founded. Prior to Cavendish, Mr. Baer was Chief Financial Officer and Vice Chairman of Brite Media Group LLC from 2005 to 2014. Brite Media Group was a media and consumer marketing company that was majority owned by Trimaran. At Brite Media Group, Mr. Baer's responsibilities included acquisitions, operations and business planning, and overall financial management including capital allocation and accounting. He evaluated hundreds of acquisition opportunities for Brite Media which resulted in closing numerous add on acquisitions and also managed the divestiture process, successfully selling a key division to a competitor in 2012 and other divisions to a private equity group in 2014. Mr. Baer previously worked for Lehman Brothers from 2000 to 2003 as an Analyst in the investment banking division. Mr. Baer graduated from Georgetown University with a Bachelor of Science in Business Administration as a finance major.- Arthur D. Baer，Gx Acquisition Corp. ii.自2021年2月起担任副总裁,2021年3月起担任Trimaran的投资专业人士，并担任GX Acquisition Corp.的顾问，GX Acquisition Corp.是一家特殊目的收购公司，于2018年8月至2021年7月与Celularity Inc.合并。此前，从2015年到2018年，他是卡文迪许基金管理公司的首席投资官，这是他创立的一家股票对冲基金。在加入卡文迪什之前，贝尔先生于2005年至2014年担任Brite Media Group LLC的Chief Financial Officer兼副主席。Brite Media Group是一家媒体和消费者营销公司，由Trimaran拥有多数股权。在Brite Media Group，Baer先生的职责包括收购、运营和业务规划，以及包括资本分配和会计在内的整体财务管理。他评估了Brite Media的数百个收购机会，这些机会导致完成了许多额外的收购，并管理了资产剥离过程，成功地在2012年将一个关键部门出售给了竞争对手，并在2014年将其他部门出售给了一家私人股本集团。Baer先生曾于2000年至2003年在雷曼兄弟公司工作，担任投资银行部门的分析师。Baer先生毕业于乔治敦大学，获得金融专业工商管理理学学士学位。
- Arthur D. Baer, Gx Acquisition Corp. Ii Vice President since February 2021, is an investment professional at Trimaran since March 2021 and was a consultant to GX Acquisition Corp., a special purpose acquisition company that merged with Celularity Inc. from August 2018 to July 2021. Previously, from 2015 to 2018, he was Chief Investment Officer of Cavendish Fund Management LLC, an equity hedge fund that he founded. Prior to Cavendish, Mr. Baer was Chief Financial Officer and Vice Chairman of Brite Media Group LLC from 2005 to 2014. Brite Media Group was a media and consumer marketing company that was majority owned by Trimaran. At Brite Media Group, Mr. Baer's responsibilities included acquisitions, operations and business planning, and overall financial management including capital allocation and accounting. He evaluated hundreds of acquisition opportunities for Brite Media which resulted in closing numerous add on acquisitions and also managed the divestiture process, successfully selling a key division to a competitor in 2012 and other divisions to a private equity group in 2014. Mr. Baer previously worked for Lehman Brothers from 2000 to 2003 as an Analyst in the investment banking division. Mr. Baer graduated from Georgetown University with a Bachelor of Science in Business Administration as a finance major.
- Jordan S. Bloom
Jordan S. Bloom，Gx Acquisition Corp. ii自2021年2月起担任副总裁，自2021年起担任Trimaran 副总裁，自2019年起担任投资专业人士。在2019年加入Trimaran之前，Bloom先生是他于2017年创立的专业金融和资产支持投资管理公司South Ave Capital的管理合伙人。在创立South Ave Capital之前，布卢姆是Aristeia Capital的一名投资专业人士，Aristeia Capital是一家价值数十亿美元的多策略投资基金。在此期间，布卢姆专注于不良信贷和特殊情况投资，规模在1000万美元至2亿美元之间，涉及广泛的行业。布卢姆之前在苏格兰皇家银行的特殊情况服务台担任研究分析师。此外，布卢姆还是康奈尔大学Triphammer Ventures and Entrepreneurship的顾问委员会成员。布鲁姆先生以优异的成绩毕业于康奈尔大学，获得金融学士学位，哥伦比亚大学商学院，获得工商管理硕士学位。Jordan S. Bloom是Gx Acquisition Corp. ii的联席主席兼首席执行官Jay R. Bloom的儿子。
Jordan S. Bloom, Gx Acquisition Corp. Ii Vice President since February 2021, has been a Vice President at Trimaran since 2021 and has been an investment professional at the firm since 2019. Prior to joining Trimaran in 2019, Mr. Bloom was the Managing Partner of South Ave Capital, a specialty finance and asset-backed investment manager that he founded in 2017. Prior to founding South Ave Capital, Mr. Bloom was an investment professional at Aristeia Capital, a multi-billion dollar, multi-strategy investment fund. While there, Mr. Bloom focused on distressed credit and special situation investments, between $10 million and $200 million in size, across a wide range of industries. Mr. Bloom previously worked as a research analyst on the Special Situations Desk at the Royal Bank of Scotland. Additionally, Mr. Bloom sits on the Board of Advisors for Triphammer Ventures and Entrepreneurship at Cornell. Mr. Bloom graduated cum laude from Cornell University with a B.S. in Finance, and from Columbia Business School with an M.B.A. Jordan S. Bloom is the son of Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer.- Jordan S. Bloom，Gx Acquisition Corp. ii自2021年2月起担任副总裁，自2021年起担任Trimaran 副总裁，自2019年起担任投资专业人士。在2019年加入Trimaran之前，Bloom先生是他于2017年创立的专业金融和资产支持投资管理公司South Ave Capital的管理合伙人。在创立South Ave Capital之前，布卢姆是Aristeia Capital的一名投资专业人士，Aristeia Capital是一家价值数十亿美元的多策略投资基金。在此期间，布卢姆专注于不良信贷和特殊情况投资，规模在1000万美元至2亿美元之间，涉及广泛的行业。布卢姆之前在苏格兰皇家银行的特殊情况服务台担任研究分析师。此外，布卢姆还是康奈尔大学Triphammer Ventures and Entrepreneurship的顾问委员会成员。布鲁姆先生以优异的成绩毕业于康奈尔大学，获得金融学士学位，哥伦比亚大学商学院，获得工商管理硕士学位。Jordan S. Bloom是Gx Acquisition Corp. ii的联席主席兼首席执行官Jay R. Bloom的儿子。
- Jordan S. Bloom, Gx Acquisition Corp. Ii Vice President since February 2021, has been a Vice President at Trimaran since 2021 and has been an investment professional at the firm since 2019. Prior to joining Trimaran in 2019, Mr. Bloom was the Managing Partner of South Ave Capital, a specialty finance and asset-backed investment manager that he founded in 2017. Prior to founding South Ave Capital, Mr. Bloom was an investment professional at Aristeia Capital, a multi-billion dollar, multi-strategy investment fund. While there, Mr. Bloom focused on distressed credit and special situation investments, between $10 million and $200 million in size, across a wide range of industries. Mr. Bloom previously worked as a research analyst on the Special Situations Desk at the Royal Bank of Scotland. Additionally, Mr. Bloom sits on the Board of Advisors for Triphammer Ventures and Entrepreneurship at Cornell. Mr. Bloom graduated cum laude from Cornell University with a B.S. in Finance, and from Columbia Business School with an M.B.A. Jordan S. Bloom is the son of Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer.
- Dean C. Kehler
Dean C. Kehler，自成立以来一直担任Celularity公司董事会成员。Kehler先生还是Trimaran的管理合伙人，Trimaran由他于1998年与他人共同创立，担任Trimaran Fund II的管理人，并担任GX Acquisition Corp. II（纳斯达克：GXII）的联席董事长兼首席执行官和董事。Kehler先生自2023年3月起担任NioCorp Developments Ltd.（纳斯达克：NB）的董事。于2005年11月至2023年3月期间，他担任El Pollo Loco Holdings, Inc.（餐厅；纳斯达克：LOCO）的董事。在加入Trimaran之前，Kehler先生是CIBC的董事总经理和副主席，负责CIBC在美国和欧洲的商业银行活动，这些活动是通过CIBC基金进行的。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆金融业务，其中包括财务发起人覆盖；收购融资；高收益发起、承销、销售和交易；私募；以及财务重组咨询服务。在加入CIBC之前，Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生在Portman Ridge Finance Corporation的董事会任职。（投资公司；纳斯达克：PTMN）和Security First Corp.（网络安全和数据管理软件），他是该公司的副董事长。他还担任宾夕法尼亚大学护理学院监督委员会成员，曾任主席。在过去五年内，他曾担任Inviva Inc.（保险）、Graphene Frontiers，LLC（石墨烯）的董事。Kehler先生此前曾担任Ashley Stewart Holdings，Inc.（零售）；Continental Airlines Inc.（航空公司；NYSE：CAL）；Global Crossing Ltd.（电信；NYSE：GX）；Hills Department Stores，Inc.（零售；NYSE：HDS）；TeleBanc Financial Corp.（互联网银行；纳斯达克：TBFC）；Booth Creek Ski Group，Inc.（房地产；休闲）；CB Holding Corp.（餐饮）；CNC Holding Corp.（零售）；Heating Oil Partners，L.P.（能源）；Jefferson National Financial Corporation（annuities）；PrimeCo Wireless Communications，LLC（通信）；Source Financing Corp.（零售）；TLC Beatrice International Inc.（消费产品）；和Urban Brands，此外，Kehler先生此前还曾担任ITC控股，Inc.（电力传动）的董事会观察员。Kehler先生此前曾担任CARE USA的董事、财务主管和财务委员会主席，CARE USA是世界上最大的私营人道主义组织之一。Kehler先生毕业于Pennsylvania大学Wharton商学院。
Dean C. Kehler,serves on the Compensation Committee of the Board. Mr. Kehler is a Managing Partner of Trimaran Capital Partners, a manager of private investment funds. Prior to co-founding Trimaran, Mr. Kehler was a vice chairman of CIBC World Markets Corp. and co-head of the CIBC Argosy Merchant Banking Funds. Prior to joining CIBC World Markets Corp. in 1995, Mr. Kehler was a founder and Managing Director of The Argosy Group L.P. Before Argosy, Mr. Kehler was a Managing Director at Drexel Burnham Lambert Incorporated and also worked at Lehman Brothers Kuhn Loeb Incorporated. Mr. Kehler currently serves on the Boards of Directors of Celularity Inc. and NioCorp Developments Ltd. Mr. Kehler previously served as a director of various public and private companies. Mr. Kehler earned his B.S. from The Wharton School of the University of Pennsylvania.- Dean C. Kehler，自成立以来一直担任Celularity公司董事会成员。Kehler先生还是Trimaran的管理合伙人，Trimaran由他于1998年与他人共同创立，担任Trimaran Fund II的管理人，并担任GX Acquisition Corp. II（纳斯达克：GXII）的联席董事长兼首席执行官和董事。Kehler先生自2023年3月起担任NioCorp Developments Ltd.（纳斯达克：NB）的董事。于2005年11月至2023年3月期间，他担任El Pollo Loco Holdings, Inc.（餐厅；纳斯达克：LOCO）的董事。在加入Trimaran之前，Kehler先生是CIBC的董事总经理和副主席，负责CIBC在美国和欧洲的商业银行活动，这些活动是通过CIBC基金进行的。此外，Kehler先生还负责监督CIBC在美国和欧洲的杠杆金融业务，其中包括财务发起人覆盖；收购融资；高收益发起、承销、销售和交易；私募；以及财务重组咨询服务。在加入CIBC之前，Kehler先生是Argosy的联合创始人。在Argosy之前，Kehler先生是Drexel Burnham Lambert Inc.的董事总经理，在此之前，他是雷曼兄弟的投资银行家。Kehler先生在Portman Ridge Finance Corporation的董事会任职。（投资公司；纳斯达克：PTMN）和Security First Corp.（网络安全和数据管理软件），他是该公司的副董事长。他还担任宾夕法尼亚大学护理学院监督委员会成员，曾任主席。在过去五年内，他曾担任Inviva Inc.（保险）、Graphene Frontiers，LLC（石墨烯）的董事。Kehler先生此前曾担任Ashley Stewart Holdings，Inc.（零售）；Continental Airlines Inc.（航空公司；NYSE：CAL）；Global Crossing Ltd.（电信；NYSE：GX）；Hills Department Stores，Inc.（零售；NYSE：HDS）；TeleBanc Financial Corp.（互联网银行；纳斯达克：TBFC）；Booth Creek Ski Group，Inc.（房地产；休闲）；CB Holding Corp.（餐饮）；CNC Holding Corp.（零售）；Heating Oil Partners，L.P.（能源）；Jefferson National Financial Corporation（annuities）；PrimeCo Wireless Communications，LLC（通信）；Source Financing Corp.（零售）；TLC Beatrice International Inc.（消费产品）；和Urban Brands，此外，Kehler先生此前还曾担任ITC控股，Inc.（电力传动）的董事会观察员。Kehler先生此前曾担任CARE USA的董事、财务主管和财务委员会主席，CARE USA是世界上最大的私营人道主义组织之一。Kehler先生毕业于Pennsylvania大学Wharton商学院。
- Dean C. Kehler,serves on the Compensation Committee of the Board. Mr. Kehler is a Managing Partner of Trimaran Capital Partners, a manager of private investment funds. Prior to co-founding Trimaran, Mr. Kehler was a vice chairman of CIBC World Markets Corp. and co-head of the CIBC Argosy Merchant Banking Funds. Prior to joining CIBC World Markets Corp. in 1995, Mr. Kehler was a founder and Managing Director of The Argosy Group L.P. Before Argosy, Mr. Kehler was a Managing Director at Drexel Burnham Lambert Incorporated and also worked at Lehman Brothers Kuhn Loeb Incorporated. Mr. Kehler currently serves on the Boards of Directors of Celularity Inc. and NioCorp Developments Ltd. Mr. Kehler previously served as a director of various public and private companies. Mr. Kehler earned his B.S. from The Wharton School of the University of Pennsylvania.
- Jay R. Bloom
Jay R. Bloom，他于2012年2月加入KCAP Financial公司的董事会。他也是Trimaran Advisors公司（公司于2012年2月收购的公司）的投资组合经理，任职于投资委员会，并担任几个证券基金投资顾问。他也是Trimaran Capital Partners公司的管理合伙人，以及私人投资基金的经理。他曾是CIBC World Markets Corp公司的副主席，以及the CIBC Argosy Merchant Banking Funds的联席主管。他曾于1995年加入CIBC World Markets公司。他是The Argosy集团的创始人兼董事总经理。他曾担任德崇证券（Drexel Burnham Lambert Incorporated）的董事总经理。他也曾任职雷曼兄弟（Lehman Brothers Kuhn Loeb Incorporated）公司。此外，他在Paul Weiss Rifkind Wharton & Garrison进行法律实践。他目前任职于Brite Media、 Educational Services of America、El Pollo Loco和Norcraft Companies公司的董事会。他获得康奈尔大学（Cornell University）的学士学位和工商管理硕士学位，以及哥伦比亚大学法学院（Columbia University School of Law）法学博士学位。他是哥伦比亚大学《法律评论》的编辑。
Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review.- Jay R. Bloom，他于2012年2月加入KCAP Financial公司的董事会。他也是Trimaran Advisors公司（公司于2012年2月收购的公司）的投资组合经理，任职于投资委员会，并担任几个证券基金投资顾问。他也是Trimaran Capital Partners公司的管理合伙人，以及私人投资基金的经理。他曾是CIBC World Markets Corp公司的副主席，以及the CIBC Argosy Merchant Banking Funds的联席主管。他曾于1995年加入CIBC World Markets公司。他是The Argosy集团的创始人兼董事总经理。他曾担任德崇证券（Drexel Burnham Lambert Incorporated）的董事总经理。他也曾任职雷曼兄弟（Lehman Brothers Kuhn Loeb Incorporated）公司。此外，他在Paul Weiss Rifkind Wharton & Garrison进行法律实践。他目前任职于Brite Media、 Educational Services of America、El Pollo Loco和Norcraft Companies公司的董事会。他获得康奈尔大学（Cornell University）的学士学位和工商管理硕士学位，以及哥伦比亚大学法学院（Columbia University School of Law）法学博士学位。他是哥伦比亚大学《法律评论》的编辑。
- Jay R. Bloom, Gx Acquisition Corp. Ii Co-Chairman and Chief Executive Officer since inception, is a Managing Partner of Trimaran Fund Management, L.L.C., d/b/a Trimaran Capital Partners ("Trimaran"), which he co-founded in 1998, and serves as a Manager of Trimaran Fund II, an existing private equity fund. Trimaran and affiliated entities have managed private equity funds, collateralized loan obligations, and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Mr. Bloom was a Managing Director and Vice Chairman of CIBC World Markets Corp. ("CIBC"), where he was responsible for CIBC's United States and European Merchant Banking activities, which were conducted through the CIBC Funds. In addition, Mr. Bloom was responsible for overseeing CIBC's United States and European Leveraged Finance businesses, which included financial sponsor coverage, acquisition finance, high yield origination, underwriting, sales and trading, private placements, and financial restructuring advisory services. Mr. Bloom was a co-founder of The Argosy Group, LP ("Argosy"), a boutique investment bank that engaged in leveraged finance activities and principal investing. Argosy was acquired by CIBC in 1995. Prior to Argosy, Mr. Bloom was a Managing Director of Drexel Burnham Lambert Inc., and before that, he was an investment banker at Lehman Brothers. Mr. Bloom also practiced law at Paul Weiss Rifkind Wharton & Garrison. Mr. Bloom has been serving on the board of directors of Celularity, Inc. (biotechnology; Nasdaq: CELU) since July 2021. Mr. Bloom has also served on the boards of many private and public companies spanning various industries. He has served on the Advisory Board of the Richman Center for Business, Law and Public Policy at Columbia University, as a member of the Cornell University Council and the Cornell University Undergraduate Business Program Advisory Council, and is an emeritus member of the Advisory Council of the Johnson Graduate School of Management at Cornell University. Mr. Bloom graduated summa cum laude from Cornell University with a B.S degree in, from the Johnson Graduate School with an M.B.A degree and from Columbia University School of Law with a J.D. degree, where he was a member of the Board of Editors of the Columbia Law Review.
- Michael G. Maselli
Michael G. Maselli自Gx Acquisition Corp. ii成立以来一直担任总裁，自2006年起担任Trimaran的董事总经理。2018年8月至2021年7月，他在GX Acquisition Corp.收购公司担任副总裁，该公司是一家与Celularity Inc.合并的特殊目的收购公司。在加入Trimaran之前，Maselli先生曾在加拿大帝国商业银行企业集团和杠杆金融集团工作。在1997年加入加拿大帝国商业银行之前，Maselli先生曾在贝尔斯登的公司融资部门担任董事总经理，在此之前，在Kidder Peabody & Co. Incorporated担任副总裁。Maselli先生作为董事或顾问指导公司及其董事会超过30年。Maselli先生自2011年起担任El Pollo Loco控股公司（Nasdaq：LOCO）的董事会主席，该公司从事餐饮业。2013年至2015年，他在Norcraft Companies, Inc.董事会任职，并于2003年开始在其前身公司董事会任职。此外，Maselli先生还在ChanceLight，Inc.（f/k/a Educational Services of America，Inc.）、Brite Media Group，Inc.和Standard Steel，LLC的董事会任职，并担任CB Holding Corp.的董事和主席。Maselli先生以优异的成绩获得杜兰大学A.B. Freeman学院的工商管理硕士学位和科罗拉多大学的经济学学士学位。
Michael G. Maselli is a managing director of Trimaran Fund, a position he has held since 2006, and was the President of Acquisitions of GX Acquisition Corp. II from Augt 2018 to March 2023. Before joining Trimaran Fund in February 2006, Mr. Maselli worked in the Corporate and Leverage Finance Groups of CIBC World Markets. Prior to joining CIBC in 1997, Mr. Maselli served as a Managing Director in Bear Stearns' corporate finance group and, prior to that, as a Vice President at Kidder Peabody & Co. Incorporated. Mr. Maselli served on the board of directors of El Pollo Loco Holdings from 2010 to 2024, and he served as their Chairman of the Board from 2011 to 2023. He served on the board of ChanceLight, Inc. (f/k/a Educational Services of America, Inc.) until 2018. From 2013 to 2015, he served on the board of directors of Norcraft Companies, Inc., and also served on the board of managers of its predecessor company beginning in 2003. Additionally, Mr. Maselli served on the board of directors of Standard Steel, LLC, and was director as ll as Chairman of the Board of CB Holding Corp. Mr. Maselli received an MBA with distinction from The A.B. Freeman School at Tulane University and a bachelor's degree in economics from the University of Colorado.- Michael G. Maselli自Gx Acquisition Corp. ii成立以来一直担任总裁，自2006年起担任Trimaran的董事总经理。2018年8月至2021年7月，他在GX Acquisition Corp.收购公司担任副总裁，该公司是一家与Celularity Inc.合并的特殊目的收购公司。在加入Trimaran之前，Maselli先生曾在加拿大帝国商业银行企业集团和杠杆金融集团工作。在1997年加入加拿大帝国商业银行之前，Maselli先生曾在贝尔斯登的公司融资部门担任董事总经理，在此之前，在Kidder Peabody & Co. Incorporated担任副总裁。Maselli先生作为董事或顾问指导公司及其董事会超过30年。Maselli先生自2011年起担任El Pollo Loco控股公司（Nasdaq：LOCO）的董事会主席，该公司从事餐饮业。2013年至2015年，他在Norcraft Companies, Inc.董事会任职，并于2003年开始在其前身公司董事会任职。此外，Maselli先生还在ChanceLight，Inc.（f/k/a Educational Services of America，Inc.）、Brite Media Group，Inc.和Standard Steel，LLC的董事会任职，并担任CB Holding Corp.的董事和主席。Maselli先生以优异的成绩获得杜兰大学A.B. Freeman学院的工商管理硕士学位和科罗拉多大学的经济学学士学位。
- Michael G. Maselli is a managing director of Trimaran Fund, a position he has held since 2006, and was the President of Acquisitions of GX Acquisition Corp. II from Augt 2018 to March 2023. Before joining Trimaran Fund in February 2006, Mr. Maselli worked in the Corporate and Leverage Finance Groups of CIBC World Markets. Prior to joining CIBC in 1997, Mr. Maselli served as a Managing Director in Bear Stearns' corporate finance group and, prior to that, as a Vice President at Kidder Peabody & Co. Incorporated. Mr. Maselli served on the board of directors of El Pollo Loco Holdings from 2010 to 2024, and he served as their Chairman of the Board from 2011 to 2023. He served on the board of ChanceLight, Inc. (f/k/a Educational Services of America, Inc.) until 2018. From 2013 to 2015, he served on the board of directors of Norcraft Companies, Inc., and also served on the board of managers of its predecessor company beginning in 2003. Additionally, Mr. Maselli served on the board of directors of Standard Steel, LLC, and was director as ll as Chairman of the Board of CB Holding Corp. Mr. Maselli received an MBA with distinction from The A.B. Freeman School at Tulane University and a bachelor's degree in economics from the University of Colorado.